Lv51
1420 积分 2023-05-11 加入
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
1个月前
已完结
Expression of ILT3 predicts poor prognosis and is inversely associated with infiltration of CD45RO+ T cells in patients with colorectal cancer
2个月前
已关闭
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
Immunogenicity to Biologics: Mechanisms, Prediction and Reduction
2个月前
已完结
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
3个月前
已完结
KIR and HLA Genotypes Influence Clinical Outcome in Multiple Myeloma Patients Treated with SAR650984 (Anti-CD38) in Combination with Lenalidomide and Dexamethasone
4个月前
已关闭
KIR and HLA Genotypes Influence Clinical Outcome in Multiple Myeloma Patients Treated with SAR650984 (Anti-CD38) in Combination with Lenalidomide and Dexamethasone
4个月前
已关闭
CAR T-cell therapy in autoimmune diseases
6个月前
已完结
Memory B cells
6个月前
已完结
皖公网安备34019202002308
